Annual CFF
$2.94 M
-$114.20 M-97.49%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual cash flow from financing activities is $2.94 million, with the most recent change of -$114.20 million (-97.49%) on December 31, 2023.
- During the last 3 years, VOR annual CFF has fallen by -$79.59 million (-96.44%).
- VOR annual CFF is now -98.74% below its all-time high of $232.91 million, reached on December 31, 2021.
Performance
VOR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$41.00 K
+$72.00 K+232.26%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly cash flow from financing activities is $41.00 thousand, with the most recent change of +$72.00 thousand (+232.26%) on September 30, 2024.
- Over the past year, VOR quarterly CFF has increased by +$16.00 thousand (+64.00%).
- VOR quarterly CFF is now -99.98% below its all-time high of $232.85 million, reached on March 31, 2021.
Performance
VOR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$131.00 K
-$135.00 K-50.75%
September 30, 2024
Summary
- As of February 8, 2025, VOR TTM cash flow from financing activities is $131.00 thousand, with the most recent change of -$135.00 thousand (-50.75%) on September 30, 2024.
- Over the past year, VOR TTM CFF has dropped by -$2.81 million (-95.54%).
- VOR TTM CFF is now -99.96% below its all-time high of $297.61 million, reached on March 31, 2021.
Performance
VOR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VOR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.5% | +64.0% | -95.5% |
| 3 y3 years | -96.4% | +64.0% | -95.5% |
| 5 y5 years | +19.2% | +64.0% | -95.5% |
VOR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.7% | at low | -100.0% | +232.3% | -99.9% | at low |
| 5 y | 5-year | -98.7% | at low | -100.0% | +109.2% | -100.0% | at low |
| alltime | all time | -98.7% | +19.2% | -100.0% | +109.2% | -100.0% | at low |
Vor Biopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $41.00 K(-232.3%) | $131.00 K(-50.8%) |
| Jun 2024 | - | -$31.00 K(-132.3%) | $266.00 K(-48.3%) |
| Mar 2024 | - | $96.00 K(+284.0%) | $515.00 K(-82.5%) |
| Dec 2023 | $2.94 M(-97.5%) | $25.00 K(-85.8%) | $2.94 M(-97.4%) |
| Sep 2023 | - | $176.00 K(-19.3%) | $115.17 M(-3.3%) |
| Jun 2023 | - | $218.00 K(-91.3%) | $119.07 M(-0.3%) |
| Mar 2023 | - | $2.52 M(-97.8%) | $119.46 M(+2.0%) |
| Dec 2022 | $117.14 M | $112.26 M(+2654.9%) | $117.14 M(+2158.8%) |
| Sep 2022 | - | $4.08 M(+574.7%) | $5.19 M(+295.3%) |
| Jun 2022 | - | $604.00 K(+202.0%) | $1.31 M(+398.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $200.00 K(-34.9%) | $263.00 K(-99.9%) |
| Dec 2021 | $232.91 M(+182.2%) | $307.00 K(+52.7%) | $232.91 M(+0.1%) |
| Sep 2021 | - | $201.00 K(-145.2%) | $232.65 M(-0.1%) |
| Jun 2021 | - | -$445.00 K(-100.2%) | $232.97 M(-21.7%) |
| Mar 2021 | - | $232.85 M(>+9900.0%) | $297.61 M(+260.6%) |
| Dec 2020 | $82.53 M(+366.3%) | $46.00 K(-91.3%) | $82.53 M(+0.1%) |
| Sep 2020 | - | $526.00 K(-99.2%) | $82.48 M(+0.6%) |
| Jun 2020 | - | $64.19 M(+261.4%) | $81.95 M(+361.4%) |
| Mar 2020 | - | $17.76 M | $17.76 M |
| Dec 2019 | $17.70 M(+618.3%) | - | - |
| Dec 2018 | $2.46 M | - | - |
FAQ
- What is Vor Biopharma annual cash flow from financing activities?
- What is the all time high annual CFF for Vor Biopharma?
- What is Vor Biopharma annual CFF year-on-year change?
- What is Vor Biopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Vor Biopharma?
- What is Vor Biopharma quarterly CFF year-on-year change?
- What is Vor Biopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Vor Biopharma?
- What is Vor Biopharma TTM CFF year-on-year change?
What is Vor Biopharma annual cash flow from financing activities?
The current annual CFF of VOR is $2.94 M
What is the all time high annual CFF for Vor Biopharma?
Vor Biopharma all-time high annual cash flow from financing activities is $232.91 M
What is Vor Biopharma annual CFF year-on-year change?
Over the past year, VOR annual cash flow from financing activities has changed by -$114.20 M (-97.49%)
What is Vor Biopharma quarterly cash flow from financing activities?
The current quarterly CFF of VOR is $41.00 K
What is the all time high quarterly CFF for Vor Biopharma?
Vor Biopharma all-time high quarterly cash flow from financing activities is $232.85 M
What is Vor Biopharma quarterly CFF year-on-year change?
Over the past year, VOR quarterly cash flow from financing activities has changed by +$16.00 K (+64.00%)
What is Vor Biopharma TTM cash flow from financing activities?
The current TTM CFF of VOR is $131.00 K
What is the all time high TTM CFF for Vor Biopharma?
Vor Biopharma all-time high TTM cash flow from financing activities is $297.61 M
What is Vor Biopharma TTM CFF year-on-year change?
Over the past year, VOR TTM cash flow from financing activities has changed by -$2.81 M (-95.54%)